EMvision Medical Devices Ltd
ASX:EMV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.465
2.68
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
EMvision Medical Devices Ltd
EMvision Medical Devices Ltd
Capital Expenditures
EMvision Medical Devices Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Capital Expenditures
-AU$302.4k
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Respiri Ltd
ASX:RSH
|
Capital Expenditures
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Capital Expenditures
-AU$3.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-59%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Capital Expenditures
-AU$905.5k
|
CAGR 3-Years
-21%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Cochlear Ltd
ASX:COH
|
Capital Expenditures
-AU$89.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Capital Expenditures
-AU$87.4k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-81%
|
CAGR 10-Years
N/A
|
|
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.
See Also
What is EMvision Medical Devices Ltd's Capital Expenditures?
Capital Expenditures
-302.4k
AUD
Based on the financial report for Jun 30, 2024, EMvision Medical Devices Ltd's Capital Expenditures amounts to -302.4k AUD.
What is EMvision Medical Devices Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-33%
Over the last year, the Capital Expenditures growth was -61%. The average annual Capital Expenditures growth rates for EMvision Medical Devices Ltd have been -33% over the past three years .
You don't have any saved screeners yet
